Clinical Trial Update: A Phase 1 Study of INCMGA00012 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 study of INCMGA00012 in patients with Locally Advanced Solid Tumors and Metastatic Solid Tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• INCMGA00012

Snippet

Sponsor: Incyte Corporation | Conditions: Locally Advanced Solid Tumors, Metastatic Solid Tumors | Phase 1 | Status: COMPLETED